Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved. 1997

M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
Institut de Recherches Jouveinal, Fresnes, France.

Because exacerbation of colitis seems to be associated with stress, we proposed evaluating the influence of stress and the involvement of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on experimental colitis in rats. Partial restraint stress was applied during 4 consecutive days, before or after intracolonic 2,4,6-trinitrobenzenesulfonic acid (TNB) instillation (15 mg) in rats. Finally, two groups of rats were centrally injected with alpha-helical CRF-(9-41) (5 micrograms) or AVP antagonist (5 micrograms) before each session of stress. Stress was applied before or right after TNB enhanced colitis, with an increase in macroscopic and histological scores and myeloperoxidase activity, alpha-Helical CRF-(9-41) or AVP antagonist had no effect on TNB-induced colitis but enhanced the effects of stress on colitis. These results show that stress may exacerbate experimental colitis in rats and that CRF and AVP are not responsible for this effect.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008297 Male Males
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D012149 Restraint, Physical Use of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION. Immobilization, Physical,Physical Restraint,Physical Immobilization,Physical Restraints,Restraints, Physical
D003092 Colitis Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER. Colitides
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D006727 Hormone Antagonists Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. Antagonists, Hormone

Related Publications

M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
January 1988, The Japanese journal of physiology,
M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
July 2016, Neuromodulation : journal of the International Neuromodulation Society,
M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
November 2001, American journal of physiology. Gastrointestinal and liver physiology,
M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
February 1994, The American journal of physiology,
M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
January 1985, Annals of the New York Academy of Sciences,
M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
April 1999, The American journal of physiology,
M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
January 1998, Life sciences,
M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
April 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience,
M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
January 1989, Peptides,
M Gué, and C Bonbonne, and J Fioramonti, and J Moré, and C Del Rio-Lachèze, and C Coméra, and L Buéno
April 1993, Indian journal of physiology and pharmacology,
Copied contents to your clipboard!